These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32639484)

  • 1. The effects of intensive speech treatment on intelligibility in Parkinson's disease: A randomised controlled trial.
    Levy ES; Moya-Galé G; Chang YHM; Freeman K; Forrest K; Brin MF; Ramig LA
    EClinicalMedicine; 2020 Jul; 24():100429. PubMed ID: 32639484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Word Intelligibility of Individuals with Parkinson's Disease in Noise: Pre-Specified Secondary Outcome Variables from a Randomized Control Trial (RCT) Comparing Two Intensive Speech Treatments (LSVT LOUD vs. LSVT ARTIC).
    Schulz G; Halpern A; Spielman J; Ramig L; Panzer I; Sharpley A; Freeman K
    Brain Sci; 2021 Jun; 11(7):. PubMed ID: 34199093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Intelligibility Deficits in Parkinson's Disease With Perceptual Speech Ratings.
    Chiu YF; Neel A
    J Speech Lang Hear Res; 2020 Feb; 63(2):433-443. PubMed ID: 32097080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic Assessment of Intelligibility in Noise in Parkinson Disease: Validation Study.
    Moya-Galé G; Walsh SJ; Goudarzi A
    J Med Internet Res; 2022 Oct; 24(10):e40567. PubMed ID: 36264608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
    Chiu Y; Neel A; Loux T
    Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson's disease (randomized controlled trial).
    Maas JJL; De Vries NM; Bloem BR; Kalf JG
    Trials; 2022 Apr; 23(1):274. PubMed ID: 35395953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of speech cues in French-speaking children with dysarthria.
    Levy ES; Moya-Galé G; Chang YM; Campanelli L; MacLeod AAN; Escorial S; Maillart C
    Int J Lang Commun Disord; 2020 May; 55(3):401-416. PubMed ID: 32077196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speech intelligibility of Parkinson's disease patients evaluated by different groups of healthcare professionals and naïve listeners.
    Carvalho J; Cardoso R; Guimarães I; Ferreira JJ
    Logoped Phoniatr Vocol; 2021 Oct; 46(3):141-147. PubMed ID: 32633172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intensive speech treatment on Mandarin speakers with Parkinson's Disease: A review.
    Chen Q; Chen B; Wan Q; Wang Y; Li J; Huang Z
    Medicine (Baltimore); 2023 Feb; 102(6):e32900. PubMed ID: 36820601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speech Intelligibility During Clinical and Low Frequency.
    Sidtis JJ; Sidtis DVL; Ramdhani R; Tagliati M
    Brain Sci; 2020 Jan; 10(1):. PubMed ID: 31906549
    [No Abstract]   [Full Text] [Related]  

  • 13. The Acoustic Voice Quality Index (AVQI) in People with Parkinson's Disease Before and After Intensive Voice and Articulation Therapies: Secondary Outcome of a Randomized Controlled Trial.
    Moya-Galé G; Spielman J; Ramig LA; Campanelli L; Maryn Y
    J Voice; 2022 Apr; ():. PubMed ID: 35450735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.
    Tjaden K; Sussman JE; Wilding GE
    J Speech Lang Hear Res; 2014 Jun; 57(3):779-92. PubMed ID: 24687042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.
    Sackley CM; Rick C; Au P; Brady MC; Beaton G; Burton C; Caulfield M; Dickson S; Dowling F; Hughes M; Ives N; Jowett S; Masterson-Algar P; Nicoll A; Patel S; Smith CH; Woolley R; Clarke CE;
    Trials; 2020 May; 21(1):436. PubMed ID: 32460885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypokinetic Dysarthria in Parkinson's Disease: A Narrative Review.
    Atalar MS; Oguz O; Genc G
    Sisli Etfal Hastan Tip Bul; 2023; 57(2):163-170. PubMed ID: 37899809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Study of Auditory-Perceptual Speech Measures for the Early Detection of Mild Speech Impairments.
    Kuruvilla-Dugdale M; Threlkeld K; Salazar M; Nolan G; Heidrick L
    Semin Speech Lang; 2019 Nov; 40(5):394-406. PubMed ID: 31426103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consonant articulation acoustics and intelligibility in Swedish speakers with Parkinson's disease: a pilot study.
    Johansson IL; Samuelsson C; Müller N
    Clin Linguist Phon; 2023 Sep; 37(9):845-865. PubMed ID: 35833475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voice improvement following conventional speech therapy combined with singing intervention in people with Parkinson's disease: A three-arm randomised controlled trial.
    Mohseni Z; Mohamadi R; Habibi SAH; Saffarian A; Abolghasemi J
    Int J Lang Commun Disord; 2023; 58(5):1752-1767. PubMed ID: 37282797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and pattern of perceived intelligibility changes in Parkinson's disease.
    Miller N; Allcock L; Jones D; Noble E; Hildreth AJ; Burn DJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1188-90. PubMed ID: 17400592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.